Showing 2361-2370 of 7016 results for "".
Taking Action Against RSV: No Child Unprotected
https://reachmd.com/programs/cme/taking-action-against-rsv-no-child-unprotected/39307/Overview of RSV epidemiology, prevention options, AAP immunization guidance, and approaches to parent–clinician communication.Individualized Cognitive Stimulation in Mild Alzheimer’s Disease: Evidence from a Multicenter RCT
https://reachmd.com/programs/neurofrontiers/individualized-cognitive-stimulation-mild-alzheimers/40001/The Role of HCC Coding in Dermatology
https://reachmd.com/topics/practice-management/the-role-of-hcc-coding-in-dermatology/56303/Hierarchical Condition Category (HCC) coding has become a cornerstone for risk adjustment in modern healthcare systems, serving to ensure appropriate reimbursement for providers managing patients with complex medical needs.Using Nerve Blocks to Avoid Pain and Narcotics for Rhinoplasty
https://reachmd.com/topics/surgical/using-nerve-blocks-to-avoid-pain-and-narcotics-for-rhinoplasty/35422/A Q&A with Anil R. Shah, MD, FACSPH Management in Unique Patients and Conditions
https://reachmd.com/programs/cme/ph-management-in-unique-patients-and-conditions/36096/Experts discuss addressing challenges that may come with managing patients with pulmonary hypertension (PH) in unique patient populations and with complex conditions.From Diagnosis to Prognosis: Using MyPath® Melanoma and DecisionDx®-Melanoma to Help Guide Patient Management Decisions
https://reachmd.com/programs/practical-dermatology/from-diagnosis-to-prognosis-using-mypath-melanoma-and-decisiondx-melanoma-to-help-guide-patient-management-decisions/39944/Gene Expression Profile Testing Helps Clinicians Clarify Diagnostically Ambiguous Lesions and Deliver Personalized, Risk-Aligned Melanoma CareThe NASH Epidemic: Highlights from the AMCP 2023 Symposium
https://reachmd.com/programs/cme/the-nash-epidemic-highlights-from-the-amcp-2023-symposium/14957/Tune in to hear key takeaways and a breakdown of clinical data from a recent satellite symposium focused on the screening and treatment NASH.Understanding Diagnostic Gaps Among Medicare Patients with ATTRwt-CM
https://reachmd.com/programs/spotlight-attr-cm/diagnostic-gaps-attrwt-cm-medicare/49049/Dupilumab in Preschool Atopic Dermatitis: Real-World Data on Efficacy and Safety
https://reachmd.com/programs/dermconsult/dupilumab-in-preschool-atopic-dermatitis-real-world-data-on-efficacy-and-safety/35497/Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
https://reachmd.com/programs/cme/muscarinic-therapies-as-a-catalyst-for-change-addressing-clinical-inertia-in-schizophrenia-care/37101/Examine muscarinic modulation as an alternative to D2 antagonists for schizophrenia, with insights on dosing, tolerability, and patient selection.